This is highly concerning, since obesity is a primary cause of health problems including but not limited to heart disease, stroke, type 2 diabetes and certain types of cancer that are some of the leading causes of preventable, premature death (CDC, 2020)
This creates a perverse incentive situation that merits discussion with your insurance provider before starting any alternating protocol
GLP-1 receptor agonists, such as semaglutide and liraglutide, have gained attention for their weight-loss effects, prompting many to ask: does GLP-1 get rid of belly fat
This matters because lean soft tissue loss comprised 26% to 40% of weight loss in recent trials of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists
Special considerations for different GLP-1 delivery methods Not all GLP-1 medications come as traditional injections, and the delivery method affects site selection considerations